Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 5
Submit an article Journal homepage
160
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Apoptosis- and cell cycle-related genes methylation profile in myeloproliferative neoplasms

Raquel TognonDepartment of Clinical, Toxicological and Bromatological Analyses, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil, ;Department of Pharmacy, School of Pharmacy, Federal University of Juiz de Fora, Governador Valadares Campus, Governador Valadares, MG, Brazil,
,
Natália S. NunesDepartment of Clinical, Toxicological and Bromatological Analyses, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil,
,
Luciana AmbrosioDepartment of Clinical, Toxicological and Bromatological Analyses, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil,
,
Elizabeth Xisto SoutoEuryclides de Jesus Zerbini Transplant Hospital, São Paulo, SP, Brazil,
,
Leila PerobelliEuryclides de Jesus Zerbini Transplant Hospital, São Paulo, SP, Brazil,
,
Belinda Pinto SimõesDepartment of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil,
,
Mariana Cristina Lima SouzaDivision of Hematology, Federal University of São Paulo, São Paulo, SP, Brazil,
,
Maria de Lourdes ChauffailleDivision of Hematology, Federal University of São Paulo, São Paulo, SP, Brazil, ;Researcher of the National Council for Scientific and Technological Development (CNPq), Brasília, DF, Brazil, and ;Fleury Institute, São Paulo, SP, Brazil
&
Fabíola Attié de CastroDepartment of Clinical, Toxicological and Bromatological Analyses, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil, ;Researcher of the National Council for Scientific and Technological Development (CNPq), Brasília, DF, Brazil, and Correspondence[email protected]
 show all
Pages 1201-1204 | Received 13 Jan 2015, Accepted 05 Jul 2015, Published online: 05 Oct 2015

References

  • Them NC, Kralovics R. Genetic basis of MPN: beyond JAK2-V617F. Curr Hematol Malig Rep 2013; 8: 299–306.
  • Pardanani AD, Levine RL, Lasho T, et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006; 108: 3472–3476.
  • Pikman Y, Lee BH, Mercher T, et al. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PloS Med 2006; 3: 1140–1151.
  • Rumi E, Harutyunyan AS, Pietra D, et al. CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis. Blood 2014; 123: 2416–2419.
  • Tognon R, Gasparotto EP, Leroy JM, et al. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases. J Clin Pathol 2011; 64: 75–82.
  • Tognon R, Gasparotto EP, Neves RP, et al. Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis. J Hematol Oncol 2012; 5: 2.
  • Gasparotto EPL, Tognon R, Ferreira AF, et al. Deregulated expression of A1, Bcl-2, Bcl-Xl, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients. Braz J Pharmaceut Sci 2011; 47: 873–886.
  • Nunes NS, Tognon R, Moura LG, et al. Differential expression of apoptomiRs in myeloproliferative neoplasms. Leuk Lymphoma 2013; 54: 2047–2051.
  • Koopmans SM, Schouten HC, van Marion AM. Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia. Pathobiology 2014; 81:60–68.
  • Zhang L, Zhao H, Sun A, et al. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia. Haematologica 2004; 89: 1199–1206.
  • Zeuner A, Pedini F, Signore M, et al. Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells. Blood 2006; 107: 3495–3502.
  • Dai C, Krantz SB. Increased expression of the INK4a/ARF locus in polycythemia vera. Blood 2001; 97: 3424–3432.
  • Furuhata A, Kimura A, Shide K, et al. P27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation. Biochem Biophys Res Commun 2009; 383:411–416.
  • Nakatake M, Monte-Mor B, Debili N, et al. JAK2(V617F) negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms. Oncogene 2011; 31: 1323–1333.
  • Mohtat D, Susztak K. Fine tuning gene expression: the epigenome. Semin Nephrol 2010; 30: 468–476.
  • Chinnaiyan AM, O’Rourke K, Yu GL, et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996; 274: 990–992.
  • Ahmad M, Srinivasula SM, Wang L, et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997; 57: 615–619.
  • Liu X, Zou H, Slaughter C, et al. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175–184.
  • Nischal S, Bhattacharyya S, Christopeit M, et al. Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms. Cancer Res 2013; 73: 1076–1085.
  • Bennemann K, Galm O, Wilop S, et al. Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation. Clin Epigenet 2012; 4: 12.
  • Pérez C, Pascual M, Martin-Subero JI, et al. Aberrant DNA methylation profile of chronic and transformed classic philadelphia-negative myeloproliferative neoplasms. Haematologica 2013; 98: 1414–1420.
  • Brakensiek K, Länger F, Kreipe H, et al. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML. Leuk Res 2005; 29: 1357–1360.
  • Quesnel B, Guillerm G, Vereecque R, et al. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood 1998; 91: 2985–2990.
  • Chim CS, Wong AS, Kwong YL. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann Hematol 2003; 82: 738–742.
  • Martin P, Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982; 216: 1233–1235.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.